In hepatocellular carcinoma, SPP1 activates the PI3K/AKT and MAPK/ERK signaling pathways, thereby enhancing the recruitment and functional activity of M2-like TAMs, suppressing CD8+ T-cell cytotoxicity, and facilitating immune evasion. Here, SPP1 is linked to hepatocellular carcinoma.